Journal All products are made under Good Manufacturing Practices (GMP) and Food Safety Moderni
2 min read
CBD modulates glutamate-GABA systems, and prefrontal-GABA systems respond uniquely in autism spectrum disorder.
November 15, 2022
Read More
2 min read
The literature is quite clear that the body’s endocannabinoid system is upregulated in obesity.
November 14, 2022
Read More
3 min read
It is too early to know the value of CBD or other cannabinoids in end-of-life care. But studies are beginning.
November 11, 2022
Read More
2 min read
CBD does not control diabetes. But it does show some ability to mitigate cardiovascular complications.
November 10, 2022
Read More Categories addiction alcohol ALS anorexia antibiotics anxiety autism autism spectrum disorder bioavailibility bioengineering bone cancer brain health brain research breast milk breastfeeding bulimia business case cancer cannabichromene cannabidiol cannabigerol cannabinoid research cannabinoid therapy cannabinoids cannabinol cannabis compounds cannabis purity cannabis regulation cannabis use disorder cannibidivarin cardiovascular CBC CBD CBD creams CBD in animals CBD market CBD oil CBD research CBDA CBDV CBG CBGA CBN cocaine cognition Community Covid-19 dementia depression diabetes drug delivery drug interactions eating disorders endocannabinoids epilepsy eye disease eye injury fibromyalgia pain food glaucoma Gummies Healthy Living Huntington's disease immune system Inaccurate labeling juvenile arthritis methamphetamines multiple sclerosis neurodegenerative diseases neuroprotection nicotine obesity OCD older people online shopping ophthalmology opioids osteoporosis pain palliative care Parkinsonism pharmaceutical cannabinoids psychiataric disorders psychosis PTSD research residual THC safety schizophrenia sex differences side effects sleep synthesis synthetic cannabinoids synthetic CBD THC the endocannabinoid system tinnitus toxicity vascular dementia
